Historical record - last NADAC effective date: 11/23/2022
Product Information
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.5694 per EA under NDC 76282067730. Its NADAC has been published 74 times since Jul 7, 2021.
FDA first approved this application on Apr 2, 2021.
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEStrength
200; 300 mg/1; mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282067730
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
11/23/2022
Active Ingredients
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA090958FDA Approved
4/2/2021
On Market Since
4/6/2021
Pharmacological Classes
Price Statistics
The NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB has been published 74 times since Jul 7, 2021, and over the history we have for it it has declined 51.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5694 per EA |
|---|---|
| All-time high | $1.5055 (Aug 11, 2021) |
| All-time low | $0.5694 (Nov 23, 2022) |
| Median price | $0.7405 |
| Average price | $0.8360 |
| Largest weekly change | -36.5% (Sep 22, 2021) |
| Weeks tracked | 74 |
| Tracking since | Jul 7, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-59.9%
All
-51.7%
Last surveyed Nov 30, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB, manufactured by Exelan Pharmaceuticals Inc., is $0.5694 per EA (NDC 76282067730), effective Nov 30, 2022.
How has the price of EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB changed over time?
Over the history we have for it, the NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB has declined 51.7%. It has been tracked across 74 weekly CMS publications since Jul 7, 2021.
What are the highest and lowest recorded NADAC prices for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB?
Since Jul 7, 2021, the NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB has ranged from a low of $0.5694 (Nov 23, 2022) to a high of $1.5055 (Aug 11, 2021), with a median of $0.7405 per EA.
Are there cheaper alternatives to EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB?
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 200-300 MG TAB (NDC 76282067730) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.